Space: The final frontier … for stem cells? Seattle’s Allen Institute for Cell Science says cells from its collection are going into space for the first time on a private… Read More
Human stem cell scientists have long dreamed of repairing damaged hearts, but have been stymied by research showing that the cells yield irregular heartbeats in laboratory animals. A new genetic engineering… Read More
Seattle’s Infectious Disease Research Institute and a New Jersey company called Celularity have been cleared by the Food and Drug Administration to start trials of an experimental cell-based therapy for… Read More
The Paul G. Allen Frontiers Group, a division of Seattle’s Allen Institute, is making a total of $7.5 million in awards to its latest class of five biomedical researchers. The… Read More
NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance of stem cells in drug development. With the acquisition, NanoSurface… Read More
Seattle-based startup Rodeo Therapeutics is raising more cash for its work on tissue repair and regeneration. The company has reeled in another $4.3 million, according to a new regulatory filing,… Read More
Medical researchers have restored the function of damaged hearts in macaque monkeys, using heart muscle cells derived from human embryonic stem cells. Now they want to do the same for… Read More
Good news, everybody: Robots can now create human mini-organs from stem cells. What could possibly go wrong? The method may sound like a nightmare from HBO’s AI thriller “WestWorld,” but… Read More
What happens when you cross cell biology with artificial intelligence? At the Allen Institute for Cell Science, the answer isn’t super-brainy microbes, but new computer models that can turn simple… Read More
Imagine being able to see inside a transparent human stem cell, like the “Visible Man and Woman” models in biology class. That’s what the Seattle-based Allen Institute for Cell Science… Read More